@article{a3697b7f822140b49c35d2e7435152a4,
title = "Innovative strategies for the elimination of viral hepatitis at a national level: A country case series",
abstract = "Viral hepatitis is a leading cause of morbidity and mortality worldwide, but has long been neglected by national and international policymakers. Recent modelling studies suggest that investing in the global elimination of viral hepatitis is feasible and cost-effective. In 2016, all 194 member states of the World Health Organization endorsed the goal to eliminate viral hepatitis as a public health threat by 2030, but complex systemic and social realities hamper implementation efforts. This paper presents eight case studies from a diverse range of countries that have invested in responses to viral hepatitis and adopted innovative approaches to tackle their respective epidemics. Based on an investment framework developed to build a global investment case for the elimination of viral hepatitis by 2030, national activities and key enablers are highlighted that showcase the feasibility and impact of concerted hepatitis responses across a range of settings, with different levels of available resources and infrastructural development. These case studies demonstrate the utility of taking a multipronged, public health approach to: (a) evidence-gathering and planning; (b) implementation; and (c) integration of viral hepatitis services into the Agenda for Sustainable Development. They provide models for planning, investment and implementation strategies for other countries facing similar challenges and resource constraints.",
keywords = "developing countries, disease elimination, hepatitis B, hepatitis C, investment case, organizational case studies",
author = "Schr{\"o}eder, {Sophia E.} and Alisa Pedrana and Nick Scott and David Wilson and Christian Kuschel and Lisa Aufegger and Rifat Atun and Ricardo Baptista-Leite and Maia Butsashvili and Manal El-Sayed and Aneley Getahun and Saeed Hamid and Radi Hammad and {{\textquoteleft}t Hoen}, Ellen and Hutchinson, {Sharon J.} and Lazarus, {Jeffrey V.} and Olufunmilayo Lesi and Wangsheng Li and {Binti Mohamed}, Rosmawati and Sigurdur Olafsson and Raquel Peck and Sohn, {Annette H.} and Mark Sonderup and Spearman, {Catherine W.} and Tracy Swan and Mark Thursz and Tim Walker and Margaret Hellard and Jessica Howell",
note = "Funding Information: Funding information This work received funding from the Qatar Foundation as part of their support for the World Innovations Summit for Health, 2018. Burnet Institute receives funding from the Victorian Operational Institute Support Program. The funders had no role in decision to publish or preparation of the manuscript. The authors gratefully acknowledge the contribution to this work of the Qatar Foundation and of the Victorian Operational Infrastructure Support Program received by Burnet Institute. We are grateful to the Brazilian Ministry of Health for their assistance in developing the Brazilian case study. We thank Dr Gottfried Hirnschall and Dr Yvan J Hutin (WHO), Giten Khwairakpam (TREAT Asia/amfAR), Dr Manik Sharma (Hamad Medical Corporation) and Dr John Thwaites (Monash University) for their contributions to the WISH 2018 Viral Hepatitis Forum Report, on which this work is built. We would like to acknowledge the contributions of Mary Ribeiro Pombo (Imperial College London and World Innovation Summit for Health (WISH, Qatar), Walid Qoronfleh (WISH, Qatar), Deidre Thompson (Imperial College London and WISH, Qatar) to the WISH 2018 Viral Hepatitis Forum. We thank Stephanie Luketic (Burnet Institute). Publisher Copyright: {\textcopyright} 2019 The Authors. Liver International published by John Wiley & Sons Ltd",
year = "2019",
month = oct,
doi = "10.1111/liv.14222",
language = "English",
volume = "39",
pages = "1818--1836",
journal = "Liver International",
issn = "1478-3223",
publisher = "Wiley-Blackwell",
number = "10",
}
